Shattuck Labs (STTK) Cash from Financing Activities (2019 - 2026)

Shattuck Labs' (STTK) quarterly Cash from Financing Activities came in at $25.8 million in Q1 2026, up 45368.42% year-on-year from N/an in Q1 2025, and up 19155.97% on a QoQ basis from $134000.0 in Q4 2025.

Shattuck Labs (STTK) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Cash from Financing Activities data on file, last reported at $25.8 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 45368.42% year-over-year to $25.8 million in Q1 2026; TTM through Mar 2026 was $70.4 million, a 7606.13% increase from a year earlier, with the FY2025 full-year figure at $44.6 million, up 5563.79% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $25.8 million, up from $134000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for STTK reached as high as $48.6 million in Q4 2023 and fell as low as -$184000.0 in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $8.6 million across 5 years, with a median of $30000.0 in 2022.
  • Across the five-year window, Cash from Financing Activities slumped 100.15% in 2024 and surged 193365.22% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at $27000.0 in 2022, then soared by 179759.26% to $48.6 million in 2023, then tumbled by 100.15% to -$72000.0 in 2024, then jumped by 286.11% to $134000.0 in 2025, then jumped by 19155.97% to $25.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $25.8 million in Q1 2026, $134000.0 in Q4 2025, and $44.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 30.14 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 53,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 68.63 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 238.74 Mn
10 Shattuck Labs 831.66 Mn 831.66 Mn - 25.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.80 Mn
Mar 31, 2026 25.80 Mn
Dec 31, 2025 134,000.00
Dec 31, 2025 134,000.00
Sep 30, 2025 44.50 Mn
Sep 30, 2025 44.50 Mn
Mar 31, 2025 -57,000.00
Mar 31, 2025 -57,000.00
Dec 31, 2024 -72,000.00
Dec 31, 2024 -72,000.00
Sep 30, 2024 23,000.00
Sep 30, 2024 23,000.00
Jun 30, 2024 1.02 Mn
Jun 30, 2024 1.02 Mn
Mar 31, 2024 -184,000.00
Mar 31, 2024 -184,000.00
Dec 31, 2023 48.56 Mn
Dec 31, 2023 48.56 Mn
Sep 30, 2023 21,000.00
Sep 30, 2023 21,000.00